NLRP3 and pulmonary arterial hypertension: The phenolic compound ellagic acid ameliorates monocrotaline-induced pulmonary artery hypertension in rats via inhibiting the NLRP3 inflammasome signaling pathway, mostly due to its anti-oxidative properties [121].